Page 46 - Read Online
P. 46

Pintos-Morell et al. Rare Dis Orphan Drugs J 2024;3:12  https://dx.doi.org/10.20517/rdodj.2023.52   Page 5 of 15

               Table 1. Different numbers of IMDs included in the conventional NBS in three selected European countries (Spain, Netherlands, and
               Italy)
                                                Treatments approved by the European   NBS-
                                                Medicines Agency (not necessarily      NBS-         NBS-
                Condition           Gene/s      implying that the treatment is available   (Andalucí  Netherlands  Italy
                                                in a specific country)        a/ Spain)
                Biotinidase deficiency  BTD     Biotin                                 X            X
                Multiple carboxylase (MCD)   HLCS  Biotin                     X        X            X
                Holocarboxylase synthetase
                deficiency
                Classic galactosemia (GALT)   GALT  Galactose free diet                X            X
                deficiency
                Galactokinase (GALK)   GALK1    Galactose/lactose-restricted diet      X
                deficiency
                Hyperphenylalaninemia (HPA)  PAH  Low phenylalanine diet, tetrahydrobiopterin  X  X   X
                Phenylketonuria (PKU)  PAH      low phenylalanine diet, pegvaliase,   X  X          X
                                                tetrahydrobiopterin
                Tetrahydrobiopterin (BH4)   GCH1, PCBD1,   Tetrahydrobiopterin, levodopa combined with a  X  Tested only if   X
                deficiency          PTS         decarboxylase inhibitor, 5-hydroxytryptophan  phenylalanine is
                                                                                       increased
                Dihydropterin reductase   QDPR  Tetrahydrobiopterin, levodopa combined with a  X  X  X
                (DHPR) deficiency               decarboxylase inhibitor, 5-hydroxytryptophan,
                                                low phenylalanine diet
                Maple syrup urine disease   BCKDHA,   Dietary management, thiamine  X  X            X
                (MSUD)              BCKDHB, DBT
                Branched-chain ketoacid   BCKDK  Dietary management, branch chain amino acid  X
                dehydrogenase kinase (BCKDK)    supplementation
                deficiency
                Tyrosinemia type 1  FAH         Nitisinone, low-phenylalanine-tyrosine diet  X  X   X
                Tyrosinemia type 2, and type 3  TAT  Low-phenylalanine-tyrosine diet  X             X
                Argininemia deficiency   ARG1   Protein restriction, liver transplant, sodium   X   X
                (ARG1D)                         benzoate, phenylbutyrate (sodium, glycerol)
                Argininosuccinic aciduria (ASA)  ASL  Protein restriction, liver transplant, sodium   X  X
                                                benzoate, phenylbutyrate (sodium, glycerol)
                Citrullinemia type 1  ASS1      Protein restriction, sodium phenylbutyrate,   X     X
                                                glycerol phenylbutyrate, L-carnitine, liver
                                                transplantation
                Citrullinemia type 2  SLC25A13  MCT milk and lactose-free milk, lipid-soluble   X   X
                                                vitamins, and ursodeoxycholic acid. Liver
                                                transplantation
                Methionine adenosyltransferase  MAT1A  Low methionine diet (some patients)   X      X
                (MAT) deficiency
                Classic Homocystinuria (CBS)   CBS  Vitamin B6 (pyridoxine), methionine-restricted  X  X
                deficiency                      diet, folate, vitamin B12, betaine
                Remethylation defects  MTHFR    Betaine, 5-methyltetrahydrofolate  X                X
                Glutaric aciduria type 1 (GA1)  GCDH  avoid fasting, carnitine, protein-restricted diet,   X  X  X
                                                restrict lysine, hydroxylysine, and tryptophan
                Isovaleric acidemia (IVA)  IVD  Low protein diet, l-carnitine, glycine  X  X        X
                3-methylglutaconic acidemia   AUH, HMGCL,   Low-protein diet, carnitine  X          X
                (primary 3-MGA)     CLPB, SERAC1
                2-methyl butyryl glycinuria   ACADSB  Carnitine               X
                (SBCAD)                         (avoidance of valproate)
                Methylmalonic acidemia   MMUT, MMAA,  IM hydroxycobalamin, carnitine, diet, N-  X  Intended to find   X
                (Mutase deficiency, CblA, CblB) MMAB  carbamylglutamate, liver transplant  only MMUT
                Methylmalonic acidemia with   MMADHC,   IM hydroxycobalamin, carnitine, diet, betaine,   X  X
                homocystinuria (CblC, CblD)  MMACHC  N-carbamylglutamate, liver transplant
                3-OH-3-methylglutaryl-CoA   HMGCL  IV glucose during acute episodes, avoid fasting,  X  X  X
                lyase deficiency (HMG)          carnitine, protein-restricted diet
                Beta-ketothiolase deficiency   ACAT1  Avoid fasting, carnitine, riboflavin, protein-  X  X
                (BKT)                           restricted diet
                Mitochondrial acetoacetyl CoA
   41   42   43   44   45   46   47   48   49   50   51